Medicine and Dentistry
Myeloma
100%
Macrophage Inflammatory Protein 1
87%
Proteasome Inhibitor
62%
Osteoclast Differentiation Factor
50%
Receptor
37%
Neoplasm
37%
Combination Therapy
37%
Development
37%
Antibody
25%
Ligand
25%
Osteolysis
25%
Plasmacytoma
25%
Cells
25%
Patient
25%
Antagonist
12%
Diseases
12%
Serum
12%
Pathogenesis
12%
Proteasome
12%
Biological Activity
12%
Tumor Progression
12%
Bone Disease
12%
Bone Atrophy
12%
Clinical Feature
12%
Systemic Administration
12%
Intratumoral Drug Administration
12%
Aldehyde
12%
Tumor Regression
12%
Paraplegia
12%
Attention
12%
Paraprotein
12%
Evaluation Study
12%
Bone Destruction
12%
Drug
12%
Chemotherapeutic Agent
12%
Growth
12%
Base
12%
Immunology and Microbiology
Macrophage Inflammatory Protein 1
87%
Monoclonals
50%
RANKL
50%
Mouse
37%
Development
37%
Monospecific Antibody
25%
Plasmacytoma
25%
Osteolysis
25%
RANK
25%
Growth
25%
Cells
25%
Bone
25%
Syngenic
12%
Proteasome
12%
Titer
12%
Biological Activity
12%
Mouse Model
12%
Tumor Volume
12%
Myeloma Protein
12%
Time
12%
Attention
12%
Biochemistry, Genetics and Molecular Biology
Proteasome Inhibitor
62%
RANKL
50%
Development
37%
Mouse
37%
Osteolysis
25%
RANK
25%
Growth
25%
Proteasome
12%
Biological Activity
12%
Titer
12%
Tumor Volume
12%
Syngenic
12%
Time
12%
Attention
12%